Adding Tirzepatide vs Prandial Insulin to Basal Insulin, Beta-Blockers in Septic Shock, USPSTF on Oral Health Screening, and more
JAMA Editors' Summary
00:00
Introduction
This chapter reviews a research article comparing the efficacy and safety of Chrysepatide and Insulinless Pro as adjunctive therapies to basal insulin in patients with Type 2 diabetes.
Transcript
Play full episode
